Granotapide (BioDeep_00000179588)

   

human metabolite blood metabolite


代谢物信息卡片


N-[2-(Dimethylcarbamoyl)-4-{2-[3-ethoxy-2-(ethoxycarbonyl)-3-oxo-2-phenylpropoxy]-2-oxoethyl}phenyl]-4-(trifluoromethyl)-[1,1-biphenyl]-2-carboximidate

化学式: C39H37F3N2O8 (718.2502)
中文名称:
谱图信息: 最多检出来源 Homo sapiens(blood) 100%

分子结构信息

SMILES: CCOC(=O)C(COC(=O)CC1=CC(=C(C=C1)NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)C(=O)N(C)C)(C4=CC=CC=C4)C(=O)OCC
InChI: InChI=1S/C39H37F3N2O8/c1-5-50-36(48)38(37(49)51-6-2,27-12-8-7-9-13-27)24-52-33(45)23-25-16-21-32(31(22-25)35(47)44(3)4)43-34(46)30-15-11-10-14-29(30)26-17-19-28(20-18-26)39(40,41)42/h7-22H,5-6,23-24H2,1-4H3,(H,43,46)

描述信息

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent

同义名列表

6 个代谢物同义名

N-[2-(Dimethylcarbamoyl)-4-{2-[3-ethoxy-2-(ethoxycarbonyl)-3-oxo-2-phenylpropoxy]-2-oxoethyl}phenyl]-4-(trifluoromethyl)-[1,1-biphenyl]-2-carboximidate; 1,3-diethyl 2-[({2-[3-(dimethylcarbamoyl)-4-[4-(trifluoromethyl)-[1,1-biphenyl]-2-amido]phenyl]acetyl}oxy)methyl]-2-phenylpropanedioate; Diethyl 2-((3-dimethylcarbamoyl-4-((4-trifluoromethylbiphenyl-2-carbonyl)amino)phenyl)acetyloxymethyl)-2-phenylmalonate; Granotapide; JTT-130; JTT 130



数据库引用编号

7 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Hideaki Yokoyama, Taku Masuyama, Yuki Tanaka, Iori Tsubakihara, Kazuma Kondo, Kouichi Yoshinari. Acyl-CoA:diacylglycerol acyltransferase 1 inhibition in the small intestine increases plasma transaminase activity via the activation of protein kinase C pathway. The Journal of toxicological sciences. 2022; 47(1):19-30. doi: 10.2131/jts.47.19. [PMID: 34987138]
  • Yasuko Mera, Takashi Kawai, Naoto Ogawa, Naoya Odani, Tomohiko Sasase, Katsuhiro Miyajima, Takeshi Ohta, Makoto Kakutani. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models. Journal of pharmacological sciences. 2015 Nov; 129(3):169-76. doi: 10.1016/j.jphs.2015.10.004. [PMID: 26598005]
  • Shohei Sakata, Sohei Katsumi, Yasuko Mera, Yukiharu Kuroki, Reiko Nashida, Makoto Kakutani, Takeshi Ohta. Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats. Journal of pharmacological sciences. 2015 Jan; 127(1):103-8. doi: 10.1016/j.jphs.2014.11.004. [PMID: 25704025]
  • Shohei Sakata, Yasuko Mera, Yukiharu Kuroki, Reiko Nashida, Makoto Kakutani, Takeshi Ohta. Combination therapy of an intestine-specific inhibitor of microsomal triglyceride transfer protein and peroxisome proliferator-activated receptor γ agonist in diabetic rat. Journal of diabetes research. 2014; 2014(?):890639. doi: 10.1155/2014/890639. [PMID: 24772450]
  • Shohei Sakata, Makoto Ito, Yasuko Mera, Tomohiko Sasase, Hiromi Yamamoto, Makoto Kakutani, Takeshi Ohta. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats. Journal of diabetes research. 2014; 2014(?):803832. doi: 10.1155/2014/803832. [PMID: 24895641]
  • Michael S Kostapanos, Evangelos C Rizos, Nikolaos Papanas, Efstratios Maltezos, Moses S Elisaf. Mitochondrial triglyceride transfer protein inhibition: new achievements in the treatment of dyslipidemias. Current pharmaceutical design. 2013; 19(17):3150-60. doi: 10.2174/1381612811319170023. [PMID: 23317403]
  • T Hata, Y Mera, T Kawai, Y Ishii, Y Kuroki, K Kakimoto, T Ohta, M Kakutani. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates impaired glucose and lipid metabolism in Zucker diabetic fatty rats. Diabetes, obesity & metabolism. 2011 Jul; 13(7):629-38. doi: 10.1111/j.1463-1326.2011.01387.x. [PMID: 21362121]
  • T Hata, Y Mera, H Tadaki, Y Kuroki, T Kawai, T Ohta, M Kakutani. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats. Diabetes, obesity & metabolism. 2011 May; 13(5):446-54. doi: 10.1111/j.1463-1326.2011.01368.x. [PMID: 21255216]
  • Takahiro Hata, Yasuko Mera, Yukihito Ishii, Hironobu Tadaki, Daisuke Tomimoto, Yukiharu Kuroki, Takashi Kawai, Takeshi Ohta, Makoto Kakutani. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner. The Journal of pharmacology and experimental therapeutics. 2011 Mar; 336(3):850-6. doi: 10.1124/jpet.110.176560. [PMID: 21139060]
  • Yasuko Mera, Naoya Odani, Takashi Kawai, Takahiro Hata, Masahiro Suzuki, Atsushi Hagiwara, Takeo Katsushima, Makoto Kakutani. Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein. The Journal of pharmacology and experimental therapeutics. 2011 Feb; 336(2):321-7. doi: 10.1124/jpet.110.173807. [PMID: 20974698]